Nymox Pharmaceutical: Lack of financial information on their website is a concern?
Summary:
1) The company moved its head office to Bahamas effective July 31, 2015, no reason was provided to its shareholders
2) Sophiris Bio vs Nymox Pharmaceutical – who is better in terms of keep shareholders updated?
3) The company’s cash reserve was very weak, raised $2.24 million vs Sophiris Bio raised $26 million in August
4) The company doesn’t have enough money to support its operations
5) The company had been posting a net loss of $5 ~ 18 million per year since 2011
Moved its Head Office to Bahamas and Why?
On August 04, 2015, Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced via news release that the Company has received formal approval to move its head office to the Bahamas effective July 31, 2015. On that news release, the company did not provide any …show more content…
The company had been posting a net loss of $5 ~ $18 million per year since 2011. Source: Nymox Pharmaceutical
Sophiris Bio vs Nymox Pharmaceutical:
Sophiris Bio Nymox Pharmaceutical
Domestic company. Must follow strict SEC regulations Foreign company. Limited SEC filings (shareholders may not get updated)
Detailed information about trials available on their website Limited information about trials available on their website
They have a timeline to complete the new trial (the Company expects to have six month biopsy data from the trial in the second half of 2017)
No timeline can be found on their website
The Company believes that its cash, cash equivalents and short-term investments, together with the net proceeds from the offering, will fund its operations into at least the second quarter of 2018.
No information available
At the end of 2nd quarter, the company had $8.3 million in cash At the end of 2nd quarter, cash and receivables including tax credits receivable totaled
Summary:
1) The company moved its head office to Bahamas effective July 31, 2015, no reason was provided to its shareholders
2) Sophiris Bio vs Nymox Pharmaceutical – who is better in terms of keep shareholders updated?
3) The company’s cash reserve was very weak, raised $2.24 million vs Sophiris Bio raised $26 million in August
4) The company doesn’t have enough money to support its operations
5) The company had been posting a net loss of $5 ~ 18 million per year since 2011
Moved its Head Office to Bahamas and Why?
On August 04, 2015, Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced via news release that the Company has received formal approval to move its head office to the Bahamas effective July 31, 2015. On that news release, the company did not provide any …show more content…
The company had been posting a net loss of $5 ~ $18 million per year since 2011. Source: Nymox Pharmaceutical
Sophiris Bio vs Nymox Pharmaceutical:
Sophiris Bio Nymox Pharmaceutical
Domestic company. Must follow strict SEC regulations Foreign company. Limited SEC filings (shareholders may not get updated)
Detailed information about trials available on their website Limited information about trials available on their website
They have a timeline to complete the new trial (the Company expects to have six month biopsy data from the trial in the second half of 2017)
No timeline can be found on their website
The Company believes that its cash, cash equivalents and short-term investments, together with the net proceeds from the offering, will fund its operations into at least the second quarter of 2018.
No information available
At the end of 2nd quarter, the company had $8.3 million in cash At the end of 2nd quarter, cash and receivables including tax credits receivable totaled